5-hydroxydecanoate has been researched along with Blood Clot in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although nicorandil has a number of beneficial cardiovascular actions, its effects on endothelial cells in the context of thrombosis have not been elucidated." | 3.75 | Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production. ( Eguchi, Y; Higashijima, N; Ishida, H; Ishizuka, N; Kawamura, Y; Takahari, Y; Tamura, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, Y | 1 |
| Takahari, Y | 1 |
| Higashijima, N | 1 |
| Ishizuka, N | 1 |
| Tamura, N | 1 |
| Kawamura, Y | 1 |
| Ishida, H | 1 |
1 other study available for 5-hydroxydecanoate and Blood Clot
| Article | Year |
|---|---|
Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production.
Topics: Animals; Anti-Arrhythmia Agents; Arteries; Cells, Cultured; Chlorides; Collagen; Decanoic Acids; End | 2009 |